NO995711D0 - Kinolin-4-karboksamid-derivater som NK-2 og NK-3-reseptorantagonister - Google Patents

Kinolin-4-karboksamid-derivater som NK-2 og NK-3-reseptorantagonister

Info

Publication number
NO995711D0
NO995711D0 NO995711A NO995711A NO995711D0 NO 995711 D0 NO995711 D0 NO 995711D0 NO 995711 A NO995711 A NO 995711A NO 995711 A NO995711 A NO 995711A NO 995711 D0 NO995711 D0 NO 995711D0
Authority
NO
Norway
Prior art keywords
quinoline
receptor antagonists
carboxamide derivatives
carboxamide
derivatives
Prior art date
Application number
NO995711A
Other languages
English (en)
Other versions
NO995711L (no
Inventor
Giuseppe Arnaldo Mari Giardina
Mario Grugni
Davide Graziani
Luca Francesco Raveglia
Original Assignee
Smithkline Beecham Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9710750.2A external-priority patent/GB9710750D0/en
Priority claimed from IT002354 external-priority patent/IT1295358B1/it
Priority claimed from ITMI972775 external-priority patent/IT1296976B1/it
Application filed by Smithkline Beecham Spa filed Critical Smithkline Beecham Spa
Publication of NO995711D0 publication Critical patent/NO995711D0/no
Publication of NO995711L publication Critical patent/NO995711L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/48—Two nitrogen atoms
    • C07D251/52—Two nitrogen atoms with an oxygen or sulfur atom attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO995711A 1997-05-23 1999-11-22 Kinolin-4-karboksamid-derivater som NK-2 og NK-3- reseptorantagonister NO995711L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9710750.2A GB9710750D0 (en) 1997-05-23 1997-05-23 Novel compounds
IT002354 IT1295358B1 (it) 1997-10-17 1997-10-17 Derivati chinolinici procedimento per la loro preparazione e uso come antagonisti del recettore nk3
ITMI972775 IT1296976B1 (it) 1997-12-16 1997-12-16 Derivati chinolinici procedimento per la loro preparazione e uso come antagonisti del recettore nk3
PCT/EP1998/003014 WO1998052942A1 (en) 1997-05-23 1998-05-18 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists

Publications (2)

Publication Number Publication Date
NO995711D0 true NO995711D0 (no) 1999-11-22
NO995711L NO995711L (no) 2000-01-19

Family

ID=27268859

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995711A NO995711L (no) 1997-05-23 1999-11-22 Kinolin-4-karboksamid-derivater som NK-2 og NK-3- reseptorantagonister

Country Status (26)

Country Link
EP (1) EP0983262B1 (no)
JP (1) JP2002500645A (no)
CN (1) CN1264378A (no)
AP (1) AP9901695A0 (no)
AR (1) AR012732A1 (no)
AT (1) ATE244711T1 (no)
AU (1) AU8209898A (no)
BG (1) BG104009A (no)
BR (1) BR9809652A (no)
CA (1) CA2291111A1 (no)
CO (1) CO4950515A1 (no)
DE (1) DE69816290T2 (no)
DZ (1) DZ2498A1 (no)
EA (1) EA199901062A1 (no)
ES (1) ES2201509T3 (no)
HU (1) HUP0002300A3 (no)
ID (1) ID22876A (no)
IL (1) IL133036A0 (no)
MA (1) MA26501A1 (no)
NO (1) NO995711L (no)
OA (1) OA11515A (no)
PE (1) PE75199A1 (no)
PL (1) PL336942A1 (no)
SK (1) SK159299A3 (no)
TR (1) TR199902883T2 (no)
WO (1) WO1998052942A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780875B2 (en) * 1998-11-20 2004-08-24 Smithkline Beecham S.P.A. Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
GB9825554D0 (en) * 1998-11-20 1999-01-13 Smithkline Beecham Spa Novel Compounds
KR20010075726A (ko) * 1998-11-20 2001-08-09 파올로 비지, 엔리꼬 카쭐라니 Ｎｋ-3 및 ｎｋ-2 수용체 길항제로서의퀴놀린-4-카르복스아미드 유도체
CA2368455A1 (en) 1999-03-29 2000-10-05 Neurogen Corporation 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
AU4802500A (en) 1999-04-26 2000-11-10 Neurogen Corporation 2-aminoquinolinecarboxamides: neurokinin receptor ligands
WO2002013825A1 (en) * 2000-08-11 2002-02-21 Smithkline Beecham P.L.C. Novel pharmaceutical use of quinnoline derivatives
JP2004517062A (ja) * 2000-11-13 2004-06-10 グラクソスミスクライン・ソシエタ・ペル・アチオニ Ｎｋ−３およびｎｋ−２アンタゴニストとしてのキノリン誘導体
GB0028964D0 (en) * 2000-11-28 2001-01-10 Smithkline Beecham Spa Novel compounds
WO2002044165A1 (en) * 2000-11-28 2002-06-06 Glaxosmithkline Spa Quinoline derivatives as nk-3 antagonists
US6540733B2 (en) 2000-12-29 2003-04-01 Corazon Technologies, Inc. Proton generating catheters and methods for their use in enhancing fluid flow through a vascular site occupied by a calcified vascular occlusion
JP2004525183A (ja) * 2001-04-11 2004-08-19 グラクソスミスクライン・ソシエタ・ペル・アチオニ Ｎｋ−３およびｎｋ−２受容体アンタゴニストとしてのキノリン−４−カルボキサミド誘導体
GB0109122D0 (en) * 2001-04-11 2001-05-30 Smithkline Beecham Spa Novel compounds
MY134211A (en) * 2001-05-18 2007-11-30 Smithkline Beecham Corp Novel use
GB0425076D0 (en) * 2004-11-12 2004-12-15 Smithkline Beecham Corp Novel compounds
GB0425075D0 (en) * 2004-11-12 2004-12-15 Smithkline Beecham Corp Novel compounds
GB0425077D0 (en) * 2004-11-12 2004-12-15 Smithkline Beecham Corp Novel compounds
AU2006253054A1 (en) * 2005-06-03 2006-12-07 Astrazeneca Ab Quinoline derivatives as NK3 anatgonists
GB0515580D0 (en) 2005-07-29 2005-09-07 Merck Sharp & Dohme Therapeutic compounds
AR057130A1 (es) 2005-09-21 2007-11-14 Astrazeneca Ab Quinolinas de alquilsulfoxido y una composicion farmaceutica
DE202007017299U1 (de) * 2007-12-12 2009-04-23 Drebo Werkzeugfabrik Gmbh Bohrer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT940391E (pt) * 1994-05-27 2004-12-31 Glaxosmithkline Spa Derivados de quinolina como antagonistas do receptor de taquicinina nk3
AR004735A1 (es) * 1995-11-24 1999-03-10 Smithkline Beecham Spa Quinoleina 4-amido sustituida, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso de los mismos para lapreparacion de un medicamento.

Also Published As

Publication number Publication date
HUP0002300A3 (en) 2002-01-28
PE75199A1 (es) 1999-10-22
NO995711L (no) 2000-01-19
BR9809652A (pt) 2001-09-11
OA11515A (en) 2004-02-04
PL336942A1 (en) 2000-07-17
CN1264378A (zh) 2000-08-23
AR012732A1 (es) 2000-11-08
AP9901695A0 (en) 1999-12-31
TR199902883T2 (xx) 2000-05-22
DZ2498A1 (fr) 2003-01-25
CA2291111A1 (en) 1998-11-26
JP2002500645A (ja) 2002-01-08
ID22876A (id) 1999-12-16
EP0983262A1 (en) 2000-03-08
DE69816290D1 (de) 2003-08-14
HUP0002300A2 (hu) 2001-06-28
WO1998052942A1 (en) 1998-11-26
SK159299A3 (en) 2000-06-12
IL133036A0 (en) 2001-03-19
MA26501A1 (fr) 2004-12-20
BG104009A (en) 2000-07-31
ES2201509T3 (es) 2004-03-16
ATE244711T1 (de) 2003-07-15
DE69816290T2 (de) 2004-05-27
EP0983262B1 (en) 2003-07-09
AU8209898A (en) 1998-12-11
EA199901062A1 (ru) 2000-08-28
CO4950515A1 (es) 2000-09-01

Similar Documents

Publication Publication Date Title
NO20012473L (no) Kinolin-4-karboksamidderivater som NK-3 og NK-2 reseptorantagonister
NO995711D0 (no) Kinolin-4-karboksamid-derivater som NK-2 og NK-3-reseptorantagonister
NO982333L (no) Kinolinkarboksamid-derivater, deres fremstilling og deres anvendelse som Neurokinin 3 (NK-3)- og Neurokinin 2 (NK-2) reseptorantagonister
NO965036D0 (no) Kinolinderivater som techykinin NK3 reseptor-antagonister
NO20013809D0 (no) Indolderivater og anvendelse derav som MCP-1 antagonister
NO20032797D0 (no) Substituerte pyridoindoler som serotonin agonister og antagonister
DK1035115T3 (da) 4-phenylpyridinderivater og anvendelse deraf som NK-1-receptorantagonister
DE69734833D1 (de) Vitronektin rezeptor antagonisten
DK0922034T3 (da) Tetrahydroquinolinderivater som EAA-antagonister
NO996115L (no) Azetidinylpropylpiperidin-derivater, intermediater og anvendelse som tachykinin-antagonister
NO990786L (no) Acylaminoalkenylen-amidderivater som NK1 og NK2 antagonister
NO20026103L (no) 1-amino-alkylcycloheksaner som 5-HT3 og neuronale nikotinreseptorantagonister
AU2002215043A1 (en) Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
NO963331D0 (no) 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister
DE69703242T2 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
DK1086093T3 (da) Tetrahydroquinolinderivater som glycinantagonister
NO994679D0 (no) Quinolin-2-karboksylsyrederivat og anvendelse derav som eksitatorisk aminosyreantagonist
DE69717449D1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
ATE211470T1 (de) Benzo(g)chinolin derivate
NO20011779D0 (no) Ureidopiperidinderivater som selektive humane NK3 reseptor antagonister
AU2002310838A1 (en) Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
AU2002308138A1 (en) 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
FI970143A0 (fi) Kinoliinijohdannaiset leukotrieeniantagonisteina
FI963463A0 (fi) Indolijohdannaiset CCK-reseptoriantagonisteina

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application